piperacillin and tazobactam (63323-304)

Drug Facts

Product Profile

Brand Name piperacillin and tazobactam

Generic Name piperacillin sodium and tazobactam sodium

Labeler fresenius kabi usa, llc

Dosage Form INJECTION, POWDER, FOR SOLUTION

Routes

INTRAVENOUS

Active Ingredients

piperacillin sodium 36 g/180mL, tazobactam sodium 4.5 g/180mL

Manufacturer

Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-304

Product ID 63323-304_c76215c6-e9f9-447a-8ce2-ecba738b25d8

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA090498

Listing Expiration 2026-12-31

Marketing Start 2011-05-31

Pharmacologic Class

Classes

penicillin-class antibacterial [epc] penicillins [cs] beta lactamase inhibitor [epc] beta lactamase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323304

Hyphenated Format 63323-304

Supplemental Identifiers

RxCUI

312447

UNII

M98T69Q7HP UXA545ABTT

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name piperacillin and tazobactam (source: ndc)

Generic Name piperacillin sodium and tazobactam sodium (source: ndc)

Application Number ANDA090498 (source: ndc)

Routes

INTRAVENOUS

source: ndc

Resolved Composition

Strengths

36 g/180mL
4.5 g/180mL

source: ndc

Packaging

1 BOTTLE in 1 CARTON (63323-304-74) / 180 mL in 1 BOTTLE

source: ndc

Packages (1)

63323-304-74 1 BOTTLE in 1 CARTON (63323-304-74) / 180 mL in 1 BOTTLE

Ingredients (2)

piperacillin sodium (36 g/180mL) tazobactam sodium (4.5 g/180mL)

Linked Drug Pages (3)

Piperacillin and Tazobactam ndc-match (0.9) Piperacillin and Tazobactam ndc-match (0.9) Piperacillin and Tazobactam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["INTRAVENOUS"], "spl_id": "c76215c6-e9f9-447a-8ce2-ecba738b25d8", "openfda": {"unii": ["M98T69Q7HP", "UXA545ABTT"], "rxcui": ["312447"], "spl_set_id": ["c78e0931-ec79-58e5-8658-7fe692dc3b8b"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (63323-304-74)  / 180 mL in 1 BOTTLE", "package_ndc": "63323-304-74", "marketing_start_date": "20110531"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "63323-304_c76215c6-e9f9-447a-8ce2-ecba738b25d8", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "63323-304", "generic_name": "Piperacillin Sodium and Tazobactam Sodium", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "36 g/180mL"}, {"name": "TAZOBACTAM SODIUM", "strength": "4.5 g/180mL"}], "application_number": "ANDA090498", "marketing_category": "ANDA", "marketing_start_date": "20110531", "listing_expiration_date": "20261231"}